Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab

International Immunopharmacology

Volumn 10, Issue 7, 2010, Pages 827-828

  Ursini, Francesco ^a   Naty, Saverio ^a   Mazzei, Valerio ^a   Spagnolo, Francesco ^a   Grembiale, Rosa Daniela ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Human herpesvirus 8; Infliximab; Kaposi's sarcoma; Psoriasis; Psoriatic arthritis

Indexed keywords

CELECOXIB; HEMOSIDERIN; INFLIXIMAB; METFORMIN; METHOTREXATE; PIROXICAM; VINBLASTINE;

ADULT; CASE REPORT; CELL PROLIFERATION; DIABETIC PATIENT; DRUG WITHDRAWAL; ELBOW; ENDOTHELIUM CELL; ERYTHEMA; ERYTHROCYTE; HAND; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; ITALY; KAPOSI SARCOMA; KNEE; LETTER; MALE; POLYARTHRITIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; SCALP; SKIN BIOPSY; SKIN DEFECT; SPINDLE CELL; TOE; WRIST;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, NEOPLASM; ARTHRITIS, PSORIATIC; EARLY DETECTION OF CANCER; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; SARCOMA, KAPOSI; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 77953022927     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.016     Document Type: Letter

References (23)

1. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., Siegel J.N., and Braun M.M. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 (2001) 1098-1104
2. Bresnihan B., and Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 29 (2003) 185-202
3. Brown S.L., Greene M.H., Gershon S.K., Edwards E.T., and Braun M.M. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthrit Rheum 46 (2002) 3151-3158
4. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpes-like DNA sequences in AIDS associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
5. Dupin N., Grandadam M., Calvez V., Gorin I., Aubin J.T., Havard S., Lamy F., Leibowitch M., Huraux J.M., Escande J.P., et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345 (1995) 761-762
6. Schalling M., Ekman M., Kaaya E.E., Linde A., and Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1 (1995) 707-708
7. Luppi M., Barozzi P., Maiorana A., Collina G., Ferrari M.G., Marasca R., Morselli M., Rossi E., Ceccherini-Nelli L., and Torelli G. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer 66 (1996) 427-431
8. Boshoff C., Schulz T.F., and Kennedy M.M. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1 (1995) 1274-1278
9. Staskus K.A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D.J., Ganem D., and Haase A.T. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71 (1997) 715-719
10. Farge D. Kaposi's sarcoma in organ transplant recipients. Eur J Med 2 (1993) 339-343
11. Farge D., Lebbe C., and Marjanovic Z. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Transplantation 67 (1999) 1236-1242
12. Franceschi S., and Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 81 (1995) 308-314
13. Geddes M., Franceschi S., Barchielli A., Falcini F., Carli S., Cocconi G., Conti E., Crosignani P., Gafà L., Giarelli L., et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69 (1994) 333-336
14. Geddes M., Franceschi S., Balzi D., Arniani S., Gafà L., and Zanetti R. Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri Tumori. J Natl Cancer Inst 87 (1995) 1015-1017
15. Whitby D., Luppi M., Barozzi P., Boshoff C., Weiss R.A., and Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer I 90 (1998) 395-397
16. + T cells. Science 242 (1998) 426
17. Lähdevirta J., Maury C.P.J., Teppo A.M., and Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85 (1998) 289
18. Oxholm A., Oxholm P., Permin H., and Bendtzen K. Epidermal tumor necrosis factor α and interleukin 6-like activities in AIDS-related Kaposi's sarcoma: an immunohistological study. APMIS 97 (1989) 533
19. Aboulafia D., Miles S.A., Saks S.R., and Mitsuyasu R.T. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acquired Immune Defic Syndr 2 (1989) 54
20. Cohen C.D., Horster S., Sander C.A., and Bogner J.R. Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis 62 7 (2003) 684
21. Kuttikat A., Joshi A., Saeed I., and Chakravarty K. Kaposi sarcoma in a patient with giant cell arteritis. Dermatol Online J 31;12 6 (2006) 16
22. Montagnino G., Bencini P.L., Tarantino A., Caputo R., and Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 14 (1994) 121-126
23. Lesnoni L.A., Parola I., Masini C., and Nanni G. Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996. Dermatology 194 (1997) 229-233